A law firm <a href=" http://weimar.edu/best-book-review-writer/#love ">research paper order exhibits</a> Prosensa developed drisapersen in partnership with GlaxoSmithKline Plc to treat Duchenne Muscular Dystrophy (DMD), a muscle-wasting disorder that affects one in every 3,500 newborn boys and has no available cure.